US FDA grants tentative approval to Zydus’s Amantadine extended-release capsules EP News Bureau Oct 10, 2022 The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ
Zydus receives final US FDA approval for Brivaracetam tablets EP News Bureau Oct 6, 2022 Brivaracetam is indicated for the treatment of partial-onset seizures in patients four years of age and older
Zydus partners with CHEMI to launch enoxaparin sodium injection EP News Bureau Aug 21, 2021 Under the agreement, CHEMI will manufacture and supply the enoxaparin sodium injection, which Zydus will commercialise in the US
